 |
 |
 |
 |
 |
 |
 |
|
|||||||
|
|
CONTENT VALIDATION AND DISCLOSURES Research To Practice (RTP) is committed to providing its participants with high-quality, unbiased and state-of-the-art education. We assess potential conflicts of interest with faculty, planners and managers of CME activities. Real or apparent conflicts of interest are identified and resolved through a conflict of interest resolution process. In addition, all activity content is reviewed by both a member of the RTP scientific staff and an external, independent physician reviewer for fair balance, scientific objectivity of studies referenced and patient care recommendations. FACULTY — The following faculty (and their spouses/partners) reported real or apparent conflicts of interest, which have been resolved through a conflict of interest resolution process: Dr Bunn — Advisory Committee: Amgen Inc, AstraZeneca Pharmaceuticals LP, Bayer Pharmaceuticals Corporation, Biogen Idec, Bristol-Myers Squibb Company, Eli Lilly and Company, Genentech BioOncology, GlaxoSmithKline, ImClone Systems Incorporated, Novartis Pharmaceuticals Corporation, OSI Oncology, Pfizer Inc, Roche Laboratories Inc, Sanofi-Aventis, Schering-Plough Corporation; Consulting Agreements: Bayer Pharmaceuticals Corporation, Biogen Idec, Eli Lilly and Company, GlaxoSmithKline. Dr Curran — Advisory Committee: Amgen Inc, AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Eli Lilly and Company, Genentech BioOncology, ImClone Systems Incorporated, Pfizer Inc; Consulting Agreements: Eli Lilly and Company, Genentech BioOncology, GPC Biotech. Dr Jablons — Speakers Bureau: AstraZeneca Pharmaceuticals LP, Eli Lilly and Company, Genentech BioOncology, OSI Oncology. Dr Kim — Advisory Committee: AstraZeneca Pharmaceuticals LP, ImClone Systems Incorporated; Paid Research: AstraZeneca Pharmaceuticals LP, Eli Lilly and Company, Genentech BioOncology, ImClone Systems Incorporated, OSI Oncology, Sanofi-Aventis; Speakers Bureau: Eli Lilly and Company, Genentech BioOncology, Sanofi-Aventis. Dr Lilenbaum — Consulting Agreement: Genentech BioOncology. Dr Lynch — Consulting Agreements: AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Eli Lilly and Company, Genentech BioOncology, ImClone Systems Incorporated, OSI Oncology, Roche Laboratories Inc, Sanofi-Aventis; Patent for EGFR Testing: Genzyme Corporation. Dr Miller — Advisory Board: Abraxis BioScience, Bayer Pharmaceuticals Corporation, Eli Lilly and Company, ImClone Systems Incorporated; Advisory Committee: Exelixis Inc, Genentech BioOncology, OSI Oncology; Consulting Agreements: Abbott Laboratories, Boehringer Ingelheim GmbH. Dr Natale — Advisory Committee: AstraZeneca Pharmaceuticals LP, Eli Lilly and Company, Genentech BioOncology, Pharmion Corporation, Roche Laboratories Inc; Consulting Agreement: Eli Lilly and Company; Paid Research: Amgen Inc, AstraZeneca Pharmaceuticals LP, Genentech BioOncology, Millennium: The Takeda Oncology Company, Pfizer Inc, Pharmion Corporation, Sanofi- Aventis; Speakers Bureau: Genentech BioOncology, OSI Oncology. Dr Socinski — Paid Research: AstraZeneca Pharmaceuticals LP, Eli Lilly and Company, Genentech BioOncology, Pfizer Inc, Sanofi- Aventis; Speakers Bureau: Eli Lilly and Company, Genentech BioOncology, Sanofi-Aventis. Dr Wozniak — Advisory Committee: AstraZeneca Pharmaceuticals LP, Eli Lilly and Company, Sanofi-Aventis; Paid Research and Speakers Bureau: Eli Lilly and Company. MODERATOR — Dr Love does not receive any direct remuneration from industry. Research To Practice receives funds in the form of educational grants to develop CME activities from the following commercial interests: Abraxis BioScience, AstraZeneca Pharmaceuticals LP, Aureon Laboratories Inc, Bayer Pharmaceuticals Corporation/Onyx Pharmaceuticals Inc, Biogen Idec, Bristol-Myers Squibb Company, Celgene Corporation, Eisai Inc, Eli Lilly and Company, Genentech BioOncology, Genomic Health Inc, GlaxoSmithKline, ImClone Systems Incorporated, Merck and Company Inc, Millennium: The Takeda Oncology Company, Novartis Pharmaceuticals Corporation, Ortho Biotech Products LP, OSI Oncology, Pfizer Inc, Roche Laboratories Inc, Sanofi-Aventis, Synta Pharmaceuticals Corp and Wyeth. RESEARCH TO PRACTICE STAFF AND EXTERNAL REVIEWERS — The scientific staff and reviewers for Research To Practice have no real or apparent conflicts of interest to disclose. This educational activity contains discussion of published and/or investigational uses of agents that are not indicated by the Food and Drug Administration. Research To Practice does not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings. The opinions expressed are those of the presenters and are not to be construed as those of the publisher or grantors.
|
|
